Building Bridges: Harmonization efforts for enhanced collaboration between developed and developing countries

Abstract

The harmonization efforts among regulatory bodies and stakeholders from developed and developing countries in the global healthcare landscape specifically focus on initiatives taken by CDSCO in India, MHLW in Japan, the TGA in Australia, ASEAN countries, and the US. The objective is to examine the importance of building bridges between these regions and harmonizing regulatory frameworks in the pharmaceutical and healthcare industries. The challenges faced include disparities in resources, technological capabilities, cultural differences, and regulatory frameworks. However, collaboration offers benefits such as increased access to affordable medicines, knowledge sharing, regulatory convergence, and capacity-building programs. International organizations like ICH play a role in facilitating harmonization efforts. Aligning regulatory systems and collaboration can enhance patient safety, facilitate trade, attract investment, and foster innovation. This paper concludes that harmonization efforts among CDSCO, MHLW, TGA, ASEAN countries, and the US can create a more integrated and equitable global healthcare ecosystem, bridging the gap between developed and developing countries.